Company intelligence / Profile preview
Cadrenal Therapeutics
Ponte Vedra, Florida, United Statescadrenal.com ↗
- Ownership
- Public · CVKD
- Employees
- ~4
- Development stage
- Phase 3
01
Overview
Tecarfarin has been evaluated in 11 human clinical trials in over 1,000 individuals. In Phase 1, Phase 2 and Phase 2/3 clinical trials, tecarfarin has generally been well-tolerated in healthy adults and patients with ESKD and chronic kidney disease (CKD). 269 patients were treated for at least 6 months and 129 patients were treated for one year or more. The FDA has provided guidance on the design of a future Phase 3 trial.
- Therapeutic areas
- HematologyCardiovascular
- Modalities
- Small molecules (oral anticoagulant)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Abbott Global Enterprises Limited (collaboration for TECH-LVAD trial)
04
Financials
- Market cap
- $4.2M
- Total revenue
- $0
- Enterprise value
- $1.9M
Beyond the preview
Go deeper on Cadrenal Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cadrenal Therapeutics.